| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.34B | 69.08B | 56.48B | 46.68B | 39.34B | 35.31B |
| Gross Profit | 21.34B | 24.71B | 21.86B | 19.84B | 14.89B | 16.65B |
| EBITDA | 4.35B | 7.38B | 4.81B | 4.61B | 2.32B | 2.19B |
| Net Income | 2.60B | 4.05B | 2.63B | 2.54B | 780.95M | 1.01B |
Balance Sheet | ||||||
| Total Assets | 106.23B | 103.86B | 92.04B | 92.13B | 69.28B | 64.18B |
| Cash, Cash Equivalents and Short-Term Investments | 52.63B | 14.63B | 19.75B | 47.52B | 12.49B | 14.08B |
| Total Debt | 45.34B | 43.32B | 42.57B | 42.64B | 33.65B | 31.55B |
| Total Liabilities | 87.44B | 82.17B | 73.18B | 75.38B | 54.42B | 49.41B |
| Stockholders Equity | 17.80B | 21.02B | 17.87B | 16.15B | 14.31B | 14.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.43B | -4.19B | 729.47M | -853.52M | -4.75B |
| Operating Cash Flow | 0.00 | 6.51B | -3.94B | 817.00M | -474.00M | -4.61B |
| Investing Cash Flow | 0.00 | 130.57M | -402.61M | -771.45M | 51.88M | -950.44M |
| Financing Cash Flow | 0.00 | -459.83M | -20.83M | 10.78B | -631.79M | 2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥67.17B | 11.62 | 17.21% | 4.27% | 13.39% | 22.06% | |
72 Outperform | ¥2.03T | 5.92 | 20.02% | 2.63% | 31.37% | 148.24% | |
71 Outperform | ¥25.31B | 14.35 | ― | 18.63% | 40.56% | 840.38% | |
70 Outperform | ¥39.44B | 6.17 | 6.18% | 4.42% | 30.88% | 193.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥18.60B | 4.77 | ― | 5.27% | 22.29% | 54.42% | |
67 Neutral | ¥120.31B | 30.49 | 5.11% | 5.07% | -26.93% | -29.39% |